Genespire is looking to take its single-dose gene therapy, GENE202, to the clinic by the end of 2026, where it will be ...
Two York business owners are launching a unique initiative for employers which blends leadership coaching with occupational therapy.
Lara Lewington has tried all the tech — and interviewed top doctors, scientists and biohackers like Bryan Johnson. Here’s ...
With Therapy Box’s strong presence in Europe and beyond, PRC-Saltillo will broaden AAC access in new regions worldwide; ...
Regene Therapeutics has received RMAT designation from the US FDA for its lead product, NouvNeu001, aimed at treating PD.
At least four businesses in the inner-city neighbourhood of Bridgeland have seen break-ins or attempted break-ins so far this ...
Two of Opus's seven gene therapy assets are in clinical trials, with additional programs expected to enter the clinic.
Nearly as soon as mental health and substance abuse organizations got notices that billions in federal grants were being ...
The company has made more than 50 deals for its proprietary technology as it looks forward to a potentially “transformative” ...
Increased CARVYKTI® manufacturing capacity with the physical expansion of the Raritan facility, now the largest cell therapy ...
Clinical and commercial quality controls are eased as the FDA looks to expedite therapy approvals in areas of unmet need.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results